Celldex Therapeutics (CLDX)
(Delayed Data from NSDQ)
$41.79 USD
+0.75 (1.83%)
Updated Mar 27, 2024 04:00 PM ET
After-Market: $41.78 -0.01 (-0.02%) 7:58 PM ET
2-Buy of 5 2
F Value F Growth C Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
05/02/2024
Time: -- |
3/2024 | $-0.67 | 0.00% |
Earnings Summary
For their last quarter, Celldex Therapeutics (CLDX) reported earnings of -$0.57 per share, beating the Zacks Consensus Estimate of $-0.76 per share. This reflects a positive earnings surprise of 25.00%. Look out for CLDX's next earnings release expected on May 02, 2024. For the next earning release, we expect the company to report earnings of -$0.67 per share, reflecting a year-over-year decrease of 8.06%.
Earnings History
Price & Consensus
Zacks News for CLDX
Celldex (CLDX) Upgraded to Buy: What Does It Mean for the Stock?
CLDX: What are Zacks experts saying now?
Zacks Private Portfolio Services